- Home
- TIMB vs PYXS Comparison
TIMB vs PYXS Comparison
Compare TIMB & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIMB
- PYXS
- Stock Information
- Founded
- TIMB 1998
- PYXS 2018
- Country
- TIMB Brazil
- PYXS United States
- Employees
- TIMB N/A
- PYXS N/A
- Industry
- TIMB Telecommunications Equipment
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- TIMB Telecommunications
- PYXS Health Care
- Exchange
- TIMB Nasdaq
- PYXS Nasdaq
- Market Cap
- TIMB 94.1M
- PYXS 79.4M
- IPO Year
- TIMB 1998
- PYXS 2021
- Fundamental
- Price
- TIMB $21.76
- PYXS $2.21
- Analyst Decision
- TIMB Hold
- PYXS Strong Buy
- Analyst Count
- TIMB 4
- PYXS 5
- Target Price
- TIMB $20.17
- PYXS $7.75
- AVG Volume (30 Days)
- TIMB 532.5K
- PYXS 900.3K
- Earning Date
- TIMB 11-04-2025
- PYXS 11-11-2025
- Dividend Yield
- TIMB 6.14%
- PYXS N/A
- EPS Growth
- TIMB 16.41
- PYXS N/A
- EPS
- TIMB 0.27
- PYXS N/A
- Revenue
- TIMB $4,779,664,328.00
- PYXS $2,820,000.00
- Revenue This Year
- TIMB $8.13
- PYXS N/A
- Revenue Next Year
- TIMB $5.28
- PYXS N/A
- P/E Ratio
- TIMB $15.59
- PYXS N/A
- Revenue Growth
- TIMB 5.32
- PYXS N/A
- 52 Week Low
- TIMB $11.32
- PYXS $0.83
- 52 Week High
- TIMB $21.82
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- TIMB 66.29
- PYXS 79.60
- Support Level
- TIMB $20.71
- PYXS $1.76
- Resistance Level
- TIMB $21.35
- PYXS $2.00
- Average True Range (ATR)
- TIMB 0.31
- PYXS 0.18
- MACD
- TIMB -0.00
- PYXS 0.05
- Stochastic Oscillator
- TIMB 92.89
- PYXS 90.38
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.